Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
03/2010
03/17/2010EP2162455A2 Pyrrolopyridine compounds, process for their preparation, and their use as medicaments
03/17/2010EP2162450A1 ((bicylicheteroaryl) imidazolyl) methylheteroaryl compounds as adrenergic receptor agonists
03/17/2010EP2161997A1 Tricyclic inhibitors of fatty acid amide hydrolase
03/17/2010EP1807068B1 Composition comprising acetaminophen, caffeine and aspirin together with an alkiline agent fr enhanced absorption
03/17/2010EP1513814B1 Novel piperidine compound
03/17/2010CN101675060A Substituted dihydro and tetrahydro oxazolopyrimidinones, preparation and use thereof
03/17/2010CN101675051A Pyrazolopyrimidine analogs and their use as mtor kinase and pi3 kinase inhibitors
03/17/2010CN101675049A Amimomethyl azaadamantane derivatives and use thereof as selective modulators of the alpha7- neuronal nicotinic acetylcholine receptor (nnrs)
03/17/2010CN101675048A 5-phenyl-6-pyridin-4-yl-1,3-dihydro-2h-imidazo[4,5-b]pyridin-2-one derivatives useful as a2b adenosine receptor antagonists
03/17/2010CN101675040A Pyridine derivatives
03/17/2010CN101675034A Pyridone derivatives as p38a mapk inhibitors
03/17/2010CN101674834A inhibitors of bruton's tyrosine kinase
03/17/2010CN101674831A Piperidine derivatives and methods of use thereof
03/17/2010CN101674827A Benzimidazole derivatives and methods of use thereof
03/17/2010CN101671599A Health-care Chinese herb spice
03/17/2010CN101671393A Angiopoietin-2 specific binding agents
03/17/2010CN101671344A Eriosema chinense flavonoid extract and extracting method and application thereof
03/17/2010CN101671319A Taxus nontoxic extract process
03/17/2010CN101671248A Long effective curcumin derivative and preparation method thereof
03/17/2010CN101670119A polynucleotide
03/17/2010CN101670110A Hydrogel controlled by hydrogen bond and pi-pi accumulation biswitch and preparation and application thereof
03/17/2010CN101670086A Chinese medicinal health wine
03/17/2010CN101670084A Liqueur-filled candy with Chinese medicinal health wine for treating sciatica
03/17/2010CN101670072A Paste for dissolving stasis and relieving pain
03/17/2010CN101670068A Medicament for treating gonarthromeningitis and preparation technology thereof
03/17/2010CN101670035A Chinese medicinal composition for treating cancerous pain and preparation method thereof
03/17/2010CN101670033A Ointment for curing protrusion of lumbar vertebral disc, sciatica, pain of neck, shoulder and legs, rheumatoid arthritis and hyperosteogeny
03/17/2010CN101670018A Method for preparing camellia saponin controlled-release tablets
03/17/2010CN101670011A Medicament for treating rheumatism and rheumatoid and preparation method thereof
03/17/2010CN101670002A Processing technique of common monkshood mother root
03/17/2010CN101669998A Corydalis saxicola pill and preparation method thereof
03/17/2010CN101669997A Transdermal administration defervescence preparation containing eugenol
03/17/2010CN101669993A Traditional Chinese medicine composition for treating chill cold for domestic animals and preparation method thereof
03/17/2010CN101669992A Distinguishing method and measuring method of perilla leaf oil
03/17/2010CN101669988A Extraction process of clerodendranthus spicatus
03/17/2010CN101669962A Composite glycyrrhizic acid amino acid injection, and preparation method as well as applications thereof
03/17/2010CN101669961A Method for producing Chinese-western compound preparation for preventing and treating animal synthetic respiratory diseases
03/17/2010CN101669945A Joint synergy of ferulic acid and matrine alkaloid and medical application thereof
03/17/2010CN101669929A Preparation method and application of ibuprofen liquid preparation
03/17/2010CN101669918A Aspirin double-releasing preparation and preparation method thereof
03/17/2010CN101669903A Preparation method of ibuprofen aminophenol injection
03/17/2010CN100594213C N-[2-(5,5-dimethyl-1,3-dioxan-2-yl)-ethyl]amino acid and its synthesis and application
03/17/2010CN100594033C Chinese traditional medicine compound took orally for treating cervical spondylotic radiculopathy
03/16/2010US7678930 Process for decreasing the amount of cholesterol in a marine oil using a volatile working fluid
03/16/2010US7678918 Induce the biosynthesis of cytokines such as interferon and tumor necrosis factor; antiviral and antitumor agents
03/16/2010US7678911 1,6 naphthyridines useful as inhibitors of SYK kinase
03/16/2010US7678887 Identification and cloning of a novel human gene, RET16, involved in the intracellular signaling cascade
03/16/2010US7678812 Aminotetralin-derived urea modulators of vanilloid VR1 receptor
03/16/2010US7678811 An urea compounds containing a pyridine, quinoline, or isoquinoline functionality; p38 mediated diseases such as inflammation and VEGF mediated diseases such as angogenesis disorders
03/16/2010US7678809 Useful in the treatment of chronic and acute pain; 1-[4-dibenzocycloheptyl-4-piperidinyl]-1,3-dihydro-2H-1,3-benzamidazol-2-one;
03/16/2010US7678801 Compounds
03/16/2010US7678798 5-({4-[(3S)-4-(5-bromo-2,3-dihydro-1H-inden-1-yl)-3-methylpiperazin-1-yl]-4-methylpiperidin-1-yl}carbonyl)-4,6-dimethylpyrimidine; inflammatory diseases, immune diseases and viral infections; HIV
03/16/2010US7678792 e.g. 3-(5-amino-2-methylphenyl)-7-chloro-1-methyl-1,6-naphthyridin-2(1H)-one; protein kinase inhibitor; antiinflammatory, anticarcinogenic, antiallergen, antidiabetic, antiischemic, hypotensive agent
03/16/2010US7678777 increase a person immunity by oral administering a mixture including a dextran, promoting the cell growth and colonizing in the intestine of a subject without supplying L. casei subsp. casei at all times
03/16/2010US7678558 Method for overexpression of zwitterionic polysaccharides
03/16/2010US7678370 Methods of preventing peritonitis by administering lactic acid bacterium
03/16/2010CA2510519C Condensed furan compounds
03/16/2010CA2500492C Aryl sulfonamides
03/16/2010CA2438646C Pyrimidine derivatives for inhibition of cell-proliferation
03/16/2010CA2437718C Carboline derivatives
03/16/2010CA2396965C Piperidine- and piperazine substituted n-hydroxyformamides as inhibitors of metalloproteinases
03/16/2010CA2395121C Composition, in particular cosmetic or dermatological composition, containing oligosaccharides and preparation method and cosmetic treatment method
03/16/2010CA2386980C Benzodiazepine derivatives for use in acute or chronic neurological disorders
03/16/2010CA2372575C Bradykinin receptor antagonists
03/16/2010CA2368617C Hydrogel-forming system with hydrophobic and hydrophilic components
03/16/2010CA2302838C Modulation of the sphingosine kinase signalling pathway
03/16/2010CA2296766C Aggrecan degrading metallo proteases
03/16/2010CA2274108C 2-cyclopenten-1-one and its derivatives as inhibitors of the nf-kb factor
03/11/2010WO2010028338A2 Novel compounds as cannabinoid receptor ligands
03/11/2010WO2010028116A1 Macrocyclics pyrimidines as aurora kinase inhibitors
03/11/2010WO2010027762A1 Indolizine inhibitors of leukotriene production
03/11/2010WO2010027594A2 Cinnamic acid-based oligomers and uses thereof
03/11/2010WO2010027500A1 Aminotriazolopyridines and their use as kinase inhibitors
03/11/2010WO2010027431A1 Substituted tricyclic acid derivatives as s1p1 receptor agonists useful in the treatment of autoimmune and inflammatory disorders
03/11/2010WO2010027189A2 A new use for homoisoflavanone or a salt thereof
03/11/2010WO2010027002A1 Ring-fused morpholine derivative having pi3k-inhibiting activity
03/11/2010WO2010026212A1 Novel inhibitors
03/11/2010WO2010026209A1 Use of isoQC inhibitors
03/11/2010WO2010026094A1 Detection and use of low molecular-weight modulators of the cold-menthol receptor trpm8
03/11/2010WO2010025630A1 Sodium cholate-included prednisone intercalated layered double hydroxides and preparation method thereof
03/11/2010WO2010025621A1 Extracts of flavonoids-containing traditional chinese medicine, extraction method, pharmaceutical composition and application thereof
03/11/2010WO2010025491A1 Treatment of neonate foals with meloxicam
03/11/2010WO2009142772A3 Methods and treatment for allergies and inflammation associated with gastrointestinal diseases
03/11/2010WO2009140642A3 Tricyclic antagonists of prostaglandin d2 receptors
03/11/2010WO2009129510A4 Sulindac formulations in a biodegradable material
03/11/2010WO2009129433A4 Alpha adrenergic receptor agonists for treatment of degenerative disc disease
03/11/2010WO2009090453A3 Compositions comprising (r) -verapamil having mt1 receptor activity
03/11/2010US20100063583 Use of soluble epoxide hydrolase inhibitors in the treatment of inflammatory vascular diseases
03/11/2010US20100063105 Pharmaceutical uses and synthesis of nicotinanilide-n-oxides
03/11/2010US20100063098 Pyridone derivatives as p38a mapk inhibitors
03/11/2010US20100063080 CXCR2 inhibitors
03/11/2010US20100063079 Pyrimidyl Sulphone Amide Derivatives as Chemokine Receptor Modulators
03/11/2010US20100063070 Combination for use in the treatment of inflammatory disorders
03/11/2010US20100063067 Cyclic derivatives as modulators of chemokine receptor activity
03/11/2010US20100063065 Thiophene derivatives as ppar agonists i
03/11/2010US20100063062 Novel use of 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoyl-benzofuran-5-yl)-piperazine and its physiologically acceptable salts
03/11/2010US20100063053 Heterocyclic inhibitors of mek and methods of use thereof
03/11/2010US20100063051 MODULATORS OF GLUCOCORTICOID RECEPTOR, AP-1, AND/OR NF-kB ACTIVITY AND USE THEREOF
03/11/2010US20100063022 Novel compounds as cannabinoid receptor ligands
03/11/2010US20100063013 Cathepsin cysteine protease inhibitors
1 ... 371 372 373 374 375 376 377 378 379 380 381 382 383 384 385 386 387 388 389 390 391 ... 1272